Cited by 1,462Cancer, Hypoxia, and MetabolismCancer Immunotherapy and BiomarkersT-cell and B-cell Immunology

The DOI matches its Crossref record; 47 of the 47 references it cites were found in a registry or an index.

Phosphoenolpyruvate Is a Metabolic Checkpoint of Anti-tumor T Cell Responses

Open access

Ho, Ping-Chih, Bihuniak, Jessica Dauz, Macintyre, Andrew N., Staron, Matthew, Liu, Xiaojing, Amezquita, Robert, Tsui, Yao-Chen, Cui, Guoliang, Micevic, Goran, Perales, Jose C., Kleinstein, Steven H., Abel, E. Dale, Insogna, Karl L., Feske, Stefan, Locasale, Jason W., Bosenberg, Marcus W., Rathmell, Jeffrey C., Kaech, Susan M.·2015·Cell

DOI 10.1016/j.cell.2015.08.012PMC PMC4567953

Open this paper in CoChat — free account Open PDF

Abstract

Activated T cells engage aerobic glycolysis and anabolic metabolism for growth, proliferation, and effector functions. We propose that a glucose-poor tumor microenvironment limits aerobic glycolysis in tumor-infiltrating T cells, which suppresses tumoricidal effector functions. We discovered a new role for the glycolytic metabolite phosphoenolpyruvate (PEP) in sustaining T cell receptor-mediated Ca(2+)-NFAT signaling and effector functions by repressing sarco/ER Ca(2+)-ATPase (SERCA) activity. Tumor-specific CD4 and CD8 T cells could be metabolically reprogrammed by increasing PEP production through overexpression of phosphoenolpyruvate carboxykinase 1 (PCK1), which bolstered effector functions. Moreover, PCK1-overexpressing T cells restricted tumor growth and prolonged the survival of melanoma-bearing mice. This study uncovers new metabolic checkpoints for T cell activity and demonstrates that metabolic reprogramming of tumor-reactive T cells can enhance anti-tumor T cell responses, illuminating new forms of immunotherapy.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Integrity signals

Registry

Crossref · 10.1016/j.cell.2015.08.012

Cites

47 of 47 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Hallmarks of Cancer: The Next Generation
Hanahan, D., & Weinberg, R. A. (2011) · Cell · doi:10.1016/j.cell.2011.02.013 · Cited by 66,590
The cBio Cancer Genomics Portal: An Open Platform for Exploring Multidimensional Cancer Genomics Data
Cerami, E., Gao, J., Dogrusoz, U., Gross, B. E., Sumer, S. O., Aksoy, B. A., Jacobsen, A., Byrne, C. J., Heuer, M. L., Larsson, E., et al. (2012) · Cancer Discovery · doi:10.1158/2159-8290.cd-12-0095 · Cited by 17,455
Adverse Renal Effects of Immune Checkpoint Inhibitors: A Narrative Review
Wanchoo, R., Karam, S., Uppal, N. N., Barta, V. S., Deray, G., Devoe, C., Launay‐Vacher, V., Jhaveri, K. D., & on behalf of Cancer and Kidney International Network Workgroup on Immune Checkpoint Inhibitors (2017) · American Journal of Nephrology · doi:10.1159/000455014 · Cited by 15,320
Integrative Analysis of Complex Cancer Genomics and Clinical Profiles Using the cBioPortal
Gao, J., Aksoy, B. A., Dogrusoz, U., Dresdner, G., Gross, B., Sumer, S. O., Sun, Y., Jacobsen, A., Sinha, R., Larsson, E., et al. (2013) · Science Signaling · doi:10.1126/scisignal.2004088 · Cited by 15,160
Chimeric Antigen Receptor T Cells for Sustained Remissions in Leukemia
Maude, S. L., Frey, N., Shaw, P. A., Aplenc, R., Barrett, D. M., Bunin, N. J., Chew, A., Gonzalez, V. E., Zheng, Z., Lacey, S. F., et al. (2014) · New England Journal of Medicine · doi:10.1056/nejmoa1407222 · Cited by 5,413
Nivolumab plus Ipilimumab in Advanced Melanoma
Wolchok, J. D., Kluger, H., Callahan, M. K., Postow, M. A., Rizvi, N. A., Lesokhin, A. M., Segal, N. H., Ariyan, C. E., Gordon, R.-A., Reed, K., et al. (2013) · New England Journal of Medicine · doi:10.1056/nejmoa1302369 · Cited by 4,230
T cell exhaustion
Wherry, E. J. (2011) · Nature Immunology · doi:10.1038/ni.2035 · Cited by 4,062 · cited 1×
“T cells displaying such properties are commonly referred to as ‘‘functionally exhausted’’ (Wherry, 2011).”
Background
Cancer immunotherapy comes of age
Mellman, I., Coukos, G., & Dranoff, G. (2011) · Nature · doi:10.1038/nature10673 · Cited by 3,893
Metabolic Reprogramming: A Cancer Hallmark Even Warburg Did Not Anticipate
Ward, P. S., & Thompson, C. B. (2012) · Cancer Cell · doi:10.1016/j.ccr.2012.02.014 · Cited by 3,233
Posttranscriptional Control of T Cell Effector Function by Aerobic Glycolysis
Chang, C.-H., Curtis, J. D., Maggi, L. B., Faubert, B., Villarino, A. V., O’Sullivan, D., Huang, S. C.-C., van der Windt, G. J. W., Blagih, J., Qiu, J., et al. (2013) · Cell · doi:10.1016/j.cell.2013.05.016 · Cited by 2,204

Show all 47 references

Sorted by citations

Items 701–800 of 1,000

Travelling under pressure - hypoxia and shear stress in the metastatic journey
Ildız, E. S., Gvozdenovic, A., Kovacs, W. J., & Aceto, N. (2023) · Clinical & Experimental Metastasis · doi:10.1007/s10585-023-10224-8 · Cited by 31
Single‐cell transcriptomics identify TNFRSF1B as a novel T‐cell exhaustion marker for ovarian cancer
Gao, Y., Shi, H., Zhao, H., Yao, M., He, Y., Jiang, M., Li, J., Li, Z., Su, S., Liu, T., et al. (2023) · Clinical and Translational Medicine · doi:10.1002/ctm2.1416 · Cited by 29
One-carbon unit supplementation fuels purine synthesis in tumor-infiltrating T cells and augments checkpoint blockade
Xu, X., Chen, Z., Bartman, C., Xing, X., Olszewski, K. L., & Rabinowitz, J. D. (2024) · Cell chemical biology · doi:10.1016/j.chembiol.2024.04.007 · Cited by 32
Glut3 overexpression improves environmental glucose uptake and antitumor efficacy of CAR-T cells in solid tumors
Hu, W., Li, F., Liang, Y., Liu, S., Wang, S., Shen, C., Zhao, Y., Wang, H., & Zhang, Y. (2025) · Journal for ImmunoTherapy of Cancer · doi:10.1136/jitc-2024-010540 · Cited by 32
Metabolic reprogramming in melanoma therapy
Shen, D., Zhang, L., Li, S., & Tang, L. (2025) · Cell Death Discovery · doi:10.1038/s41420-025-02617-3 · Cited by 32
Topical Diclofenac Reprograms Metabolism and Immune Cell Infiltration in Actinic Keratosis
Singer, K., Dettmer, K., Unger, P., Schoenhammer, G., Renner, K., Peter, K., Siska, P. J., Berneburg, M., Herr, W., Oefner, P. J., et al. (2019) · Frontiers in Oncology · doi:10.3389/fonc.2019.00605 · Cited by 29
Natural Compounds as Metabolic Modulators of the Tumor Microenvironment
Dias, A. S., Helguero, L. A., Almeida, C. R., & Duarte, I. F. (2021) · Molecules · doi:10.3390/molecules26123494 · Cited by 31
MYC Ran Up the Clock: The Complex Interplay between MYC and the Molecular Circadian Clock in Cancer
Burchett, J. B., Knudsen-Clark, A. M., & Altman, B. J. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22147761 · Cited by 32
NKT cells adopt a glutamine-addicted phenotype to regulate their homeostasis and function
Kumar, A., Yarosz, E. L., Andren, A. C., Zhang, L., Lyssiotis, C. A., & Chang, C. (2022) · Cell Reports · doi:10.1016/j.celrep.2022.111516 · Cited by 32
Metabolic Signaling Drives IFN-γ
Siska, P. J., & Rathmell, J. C. (2016) · Cell Metabolism · doi:10.1016/j.cmet.2016.10.018 · Cited by 29
Self-citation
Metabolism of T Lymphocytes in Health and Disease
Gaber, T., Chen, Y., Krauß, P.-L., & Buttgereit, F. (2018) · International review of cytology · doi:10.1016/bs.ircmb.2018.06.002 · Cited by 32
Role of Hypoxia in the Interferon Response
Arnaiz, E., & Harris, A. L. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.821816 · Cited by 28
Reprogramming the immunosuppressive tumor microenvironment: exploiting angiogenesis and thrombosis to enhance immunotherapy
Shafqat, A., Omer, M. H., Ahmed, E. N., Mushtaq, A. H., Ijaz, E., Ahmed, Z., AlKattan, K. M., & Yaqinuddin, A. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1200941 · Cited by 32
Shaping immune landscape of colorectal cancer by cholesterol metabolites
Bai, Y., Li, T., Wang, Q., You, W., Yang, H., Xu, X., Li, Z., Zhang, Y., Yan, C., Yang, L., et al. (2024) · EMBO Molecular Medicine · doi:10.1038/s44321-023-00015-9 · Cited by 31
Self-citation
Potassium shapes antitumor immunity
Baixauli, F., Villa, M., & Pearce, E. L. (2019) · Science · doi:10.1126/science.aaw8800 · Cited by 27
Tumor hypermetabolism confers resistance to immunotherapy
Liu, A. J., & Curran, M. A. (2020) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2020.01.009 · Cited by 29
Multifaceted Aspects of Metabolic Plasticity in Human Cholangiocarcinoma: An Overview of Current Perspectives
Pastore, M., Lori, G., Gentilini, A., Taddei, M. L., Maira, G. D., Campani, C., Recalcati, S., Invernizzi, P., Marra, F., & Raggi, C. (2020) · Cells · doi:10.3390/cells9030596 · Cited by 28
Harnessing Metabolic Reprogramming to Improve Cancer Immunotherapy
Liang, Y., Tan, Y., Chen, G., Fan, J., & Zhang, J. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms221910268 · Cited by 29
Novel aspects of regulatory T cell dysfunction as a therapeutic target in giant cell arteritis
Adriawan, I. R., Atschekzei, F., Dittrich‐Breiholz, O., Garantziotis, P., Hirsch, S., Risser, L. M., Kosanke, M., Schmidt, R. E., Witte, T., & Sogkas, G. (2021) · Annals of the Rheumatic Diseases · doi:10.1136/annrheumdis-2021-220955 · Cited by 28
Tumorous expression of NAC1 restrains antitumor immunity through the LDHA-mediated immune evasion
Ren, Y., Kumar, A., Das, J. K., Peng, H., Wang, L., Ballard, D. J., Xiong, X., Ren, X., Zhang, Y., Yang, J., et al. (2022) · Journal for ImmunoTherapy of Cancer · doi:10.1136/jitc-2022-004856 · Cited by 30
Emerging strategies for delivering antiangiogenic therapies to primary and metastatic brain tumors
Askoxylakis, V., Arvanitis, C., Wong, C. S. F., Ferraro, G. B., & Jain, R. K. (2017) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2017.06.011 · Cited by 27
Innate and Adaptive Immune Cell Metabolism in Tumor Microenvironment
Wu, D. (2017) · Advances in experimental medicine and biology · doi:10.1007/978-94-024-1170-6_7 · Cited by 27
The role of tumor metabolism in modulating T-Cell activity and in optimizing immunotherapy
Ganjoo, S., Gupta, P., Corbali, H. I., Nanez, S., Riad, T. S., Duong, L. K., Barsoumian, H. B., Masrorpour, F., Jiang, H., Welsh, J. W., et al. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1172931 · Cited by 32
Genetically engineering glycolysis in T cells increases their antitumor function
Zur-Toledano, R., Atar, O., Barliya, T., Hoogi, S., Abramovich, I., Gottlieb, E., Ron‐Harel, N., & Cohen, C. J. (2024) · Journal for ImmunoTherapy of Cancer · doi:10.1136/jitc-2023-008434 · Cited by 27
Tumor Metabolic Reprogramming and Ferroptosis: The Impact of Glucose, Protein, and Lipid Metabolism
Zhu, K., Cai, Y., Lan, L., & Luo, N. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms252413413 · Cited by 33
Abrogation of esophageal carcinoma development in miR-31 knockout rats
Fong, L. Y. Y., Taccioli, C., Palamarchuk, A., Tagliazucchi, G. M., Jing, R., Smalley, K. J., Fan, S., Altemus, J., Fiehn, O., Huebner, K., et al. (2020) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1920333117 · Cited by 27
Advances in Intracellular Calcium Signaling Reveal Untapped Targets for Cancer Therapy
Sharma, A., Ramena, G. T., & Elble, R. C. (2021) · Biomedicines · doi:10.3390/biomedicines9091077 · Cited by 29
Purinergic receptors are a key bottleneck in tumor metabolic reprogramming: The prime suspect in cancer therapeutic resistance
Aria, H., Rezaei, M., Nazem, S., Daraei, A., Nikfar, G., Mansoori, B., Bahmanyar, M., Tavassoli, A., Vakil, M. K., & Mansoori, Y. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.947885 · Cited by 26
Metabolic features of innate lymphoid cells
Yu, H., Jacquelot, N., & Belz, G. T. (2022) · The Journal of Experimental Medicine · doi:10.1084/jem.20221140 · Cited by 31
Tumor interstitial fluid analysis enables the study of microenvironment–cell interactions in cancers
Saab, J. J. A., & Muir, A. (2023) · Current Opinion in Biotechnology · doi:10.1016/j.copbio.2023.102970 · Cited by 27
Reprogramming of tumor-associated macrophages by metabolites generated from tumor microenvironment
Kim, S. W., Kim, C. W., Moon, Y.-A., & Kim, H. S. (2024) · Animal Cells and Systems · doi:10.1080/19768354.2024.2336249 · Cited by 28
Analysis of 13C and 14C labeling in pyruvate and lactate in tumor and blood of lymphoma‐bearing mice injected with 13C‐ and 14C‐labeled pyruvate
Serrão, E. M., Kettunen, M. I., Rodrigues, T. B., Lewis, D. Y., Gallagher, F. A., Hu, D., & Brindle, K. M. (2018) · NMR in Biomedicine · doi:10.1002/nbm.3901 · Cited by 26
miR-155 Overexpression in OT-1 CD8+ T Cells Improves Anti-Tumor Activity against Low-Affinity Tumor Antigen
Monnot, G., Martínez-Usatorre, A., Lanitis, E., Lopes, S. F., Cheng, W.-C., Ho, P., Irving, M. B., Coukos, G., Donda, A., & Romero, P. J. (2019) · Molecular Therapy — Oncolytics · doi:10.1016/j.omto.2019.12.008 · Cited by 26
Self-citation
Engineering Metabolism of Chimeric Antigen Receptor (CAR) Cells for Developing Efficient Immunotherapies
Mangal, J. L., Handlos, J. L., Esrafili, A., Inamdar, S., Mcmillian, S., Wankhede, M., Gottardi, R., & Acharya, A. P. (2021) · Cancers · doi:10.3390/cancers13051123 · Cited by 26
Reversing the mitochondrial stress-induced exhaustion of CD8+ T cells for improving cancer immunotherapy
Qian, C., & Cao, X. (2021) · Cellular and Molecular Immunology · doi:10.1038/s41423-021-00709-5 · Cited by 26
Multistability maintains redox homeostasis in human cells
Huang, J., Co, H. K. C., Lee, Y., Wu, C., & Chen, S. (2021) · Molecular Systems Biology · doi:10.15252/msb.202110480 · Cited by 26
Importance of T, NK, CAR T and CAR NK Cell Metabolic Fitness for Effective Anti-Cancer Therapy: A Continuous Learning Process Allowing the Optimization of T, NK and CAR-Based Anti-Cancer Therapies
Krug, A., Martinez-Turtos, A., & Verhoeyen, E. (2021) · Cancers · doi:10.3390/cancers14010183 · Cited by 28
Uptake of long-chain fatty acids from the bone marrow suppresses CD8+ T-cell metabolism and function in multiple myeloma
Gudgeon, N. H., Giles, H. V., Bishop, E. L., Fulton-Ward, T., Escribano-Gonzalez, C., Munford, H., James-Bott, A., Foster, K. A., Karim, F., Jayawardana, D., et al. (2023) · Blood Advances · doi:10.1182/bloodadvances.2023009890 · Cited by 29
Prostaglandin E2 controls the metabolic adaptation of T cells to the intestinal microenvironment
Villa, M., Sanin, D. E., Apostolova, P., Corrado, M., Kabat, A. M., Cristinzio, C., Regina, A., Carrizo, G., Rana, N., Stanczak, M. A., et al. (2024) · Nature Communications · doi:10.1038/s41467-024-44689-2 · Cited by 30
Augmentation of glycolytic metabolism by meclizine is indispensable for protection of dorsal root ganglion neurons from hypoxia-induced mitochondrial compromise
Zhuo, M., Gorgun, M. F., & Englander, E. W. (2016) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2016.07.022 · Cited by 24
Filling the Tank: Keeping Antitumor T Cells Metabolically Fit for the Long Haul
Delgoffe, G. M. (2016) · Cancer Immunology Research · doi:10.1158/2326-6066.cir-16-0244 · Cited by 26
Immunometabolism regulates TCR recycling and iNKT cell functions
Fu, S., Zhu, S., Tian, C., Bai, S., Zhang, J., Zhan, C., Xie, D., Wang, L., Li, Z., Li, J., et al. (2019) · Science Signaling · doi:10.1126/scisignal.aau1788 · Cited by 27
Metabolic checkpoints and novel approaches for immunotherapy against cancer
Li, Y., Tang, J., Jiang, J., & Chen, Z. (2021) · International Journal of Cancer · doi:10.1002/ijc.33781 · Cited by 29
Metabolic plasticity of T cell fate decision
Pan, X., Wang, J., Zhang, L., Li, G., & Huang, B. (2023) · Chinese Medical Journal · doi:10.1097/cm9.0000000000002989 · Cited by 26
Unlocking the potential: Targeting metabolic pathways in the tumor microenvironment for Cancer therapy
Jia, S., Bode, A. M., Chen, X., & Luo, X. (2024) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2024.189166 · Cited by 27
Barriers and solutions for CAR-T therapy in solid tumors
Tu, Z., Chen, Y., Zhang, Z., Meng, W., & Li, L. (2025) · Cancer Gene Therapy · doi:10.1038/s41417-025-00931-7 · Cited by 32
Tumor-instructed glutamine synthesis in cancer-associated fibroblasts promotes pro-tumor macrophages
Li, X., Møller, S. H., Park, J., Chuang, Y., Hsueh, P., Chang, T.-H., Kao, K., Gallart‐Ayala, H., Wang, Y., Peng, J.-J., et al. (2025) · The Journal of Experimental Medicine · doi:10.1084/jem.20241426 · Cited by 27
Self-citation
Metabolism of Stem and Progenitor Cells: Proper Methods to Answer Specific Questions
Martano, G., Borroni, E. M., Lopci, E., Cattaneo, M. G., Mattioli, M., Bachi, A., Decimo, I., & Bifari, F. (2019) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2019.00151 · Cited by 24
Receptor signaling, transcriptional, and metabolic regulation of T cell exhaustion
Balkhi, M. Y. (2020) · OncoImmunology · doi:10.1080/2162402x.2020.1747349 · Cited by 26
Metabolism in the Tumor Microenvironment
Montenegro, F., & Indraccolo, S. (2020) · Advances in experimental medicine and biology · doi:10.1007/978-3-030-44518-8_1 · Cited by 26
Tumor Cell-Intrinsic Immunometabolism and Precision Nutrition in Cancer Immunotherapy
Cuyàs, E., Verdura, S., Martín-Castillo, B., Alarcón, T., Lupu, R., Bosch‐Barrera, J., & Menéndez, J. A. (2020) · Cancers · doi:10.3390/cancers12071757 · Cited by 26
Development and validation of prognostic model for predicting mortality of COVID-19 patients in Wuhan, China
Mei, Q., Wang, Y., Bryant, A. E., Yang, Y., Li, M., Wang, F., Zhao, J. W., Ma, K., Wu, L., Chen, H., et al. (2020) · Scientific Reports · doi:10.1038/s41598-020-78870-6 · Cited by 28
MicroRNA-Mediated Metabolic Shaping of the Tumor Microenvironment
Virga, F., Quirico, L., Cucinelli, S., Mazzone, M., Taverna, D., & Orso, F. (2021) · Cancers · doi:10.3390/cancers13010127 · Cited by 25
PEPCK-M recoups tumor cell anabolic potential in a PKC-ζ-dependent manner
Hyroššová, P., Aragó, M., Moreno-Felici, J., Fu, X., Méndez‐Lucas, A., García-Rovés, P. M., Burgess, S. C., Figueras, A., Viñals, F., & Perales, J. C. (2021) · Cancer & Metabolism · doi:10.1186/s40170-020-00236-3 · Cited by 25
Self-citation
Tinkering under the Hood: Metabolic Optimisation of CAR-T Cell Therapy
Jenkins, Y. R., Zabkiewicz, J., Ottmann, O. G., & Jones, N. (2021) · Antibodies · doi:10.3390/antib10020017 · Cited by 24
Immunometabolism: A ‘Hot’ Switch for ‘Cold’ Pediatric Solid Tumors
Xiao, L., Yeung, H., Haber, M., Norris, M. D., & Somers, K. (2021) · Trends in cancer · doi:10.1016/j.trecan.2021.05.002 · Cited by 24
Pathophysiological Integration of Metabolic Reprogramming in Breast Cancer
Corchado‐Cobos, R., García‐Sancha, N., Mendiburu‐Eliçabe, M., Gómez-Vecino, A., Jiménez‐Navas, A., Pérez‐Baena, M. J., Holgado-Madruga, M., Mao, J., Cañueto, J., Castillo‐Lluva, S., et al. (2022) · Cancers · doi:10.3390/cancers14020322 · Cited by 27
Cancer Metabolism: The Role of Immune Cells Epigenetic Alteration in Tumorigenesis, Progression, and Metastasis of Glioma
Kanwore, K., Kanwore, K., Adzika, G. K., Abiola, A. A., Guo, X., Kambey, P. A., Xia, Y., & Gao, D. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.831636 · Cited by 26
Metabolism and senescence in the immune microenvironment of osteosarcoma: focus on new therapeutic strategies
Ying, H., Li, Z., Li, M.-P., & Liu, W. (2023) · Frontiers in Endocrinology · doi:10.3389/fendo.2023.1217669 · Cited by 29
Anti PD-1 treatment increases [18F]FDG uptake by cancer cells in a mouse B16F10 melanoma model
Tomita, M., Yasui, H., Higashikawa, K., Nakajima, K., Takakura, H., Shiga, T., Kuge, Y., & Ogawa, M. (2018) · EJNMMI Research · doi:10.1186/s13550-018-0433-1 · Cited by 25
Metabolic immunoengineering approaches to enhance CD8+ T cell-based cancer immunotherapy
Feng, B., Li, R., Li, W., & Tang, L. (2024) · Cell Systems · doi:10.1016/j.cels.2024.11.010 · Cited by 27
Advances in Cancer Treatment Through Nanotheranostics and Emerging Therapies
Akpe, V., & Cock, I. E. (2025) · Journal of Nanotheranostics · doi:10.3390/jnt6040029 · Cited by 27
Oncogenic KRAS mutations drive immune suppression through immune-related regulatory network and metabolic reprogramming
Tian, L., Li, H., Cui, H., Tang, C., Zhao, P., Wang, X., & Cheng, Y. (2025) · Cell Death and Disease · doi:10.1038/s41419-025-08101-1 · Cited by 26
Isolation and Quantification of Metabolite Levels in Murine Tumor Interstitial Fluid by LC/MS
Sullivan, M. R., Lewis, C. A., & Muir, A. (2019) · BIO-PROTOCOL · doi:10.21769/bioprotoc.3427 · Cited by 28
Role of Bladder Cancer Metabolic Reprogramming in the Effectiveness of Immunotherapy
Scholtes, M., de Jong, F. C., Zuiverloon, T. C. M., & Theodorescu, D. (2021) · Cancers · doi:10.3390/cancers13020288 · Cited by 24
Differential Fuel Requirements of Human NK Cells and Human CD8 T Cells: Glutamine Regulates Glucose Uptake in Strongly Activated CD8 T Cells
Presnell, S. R., Spear, H. K., Durham, J., Riddle, T., Applegate, A., & Lutz, C. T. (2020) · ImmunoHorizons · doi:10.4049/immunohorizons.2000020 · Cited by 24
Molecular Characteristics of T Cell-Mediated Tumor Killing in Hepatocellular Carcinoma
Hong, W.-F., Liu, M.-Y., Liang, L., Zhang, Y., Li, Z., Han, K.-Q., Du, S., Chen, Y., & Ma, L. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.868480 · Cited by 25
Increased serum level of soluble interleukin-2 receptor is associated with a worse response of metastatic clear cell renal cell carcinoma to interferon alpha and sequential VEGF-targeting therapy
Nukui, A., Masuda, A., Abe, H., Arai, K., Yoshida, K., & Kamai, T. (2017) · BMC Cancer · doi:10.1186/s12885-017-3369-3 · Cited by 23
The estrogen-related receptors in metabolism and cancer: newer insights
Ranhotra, H. S. (2018) · Journal of Receptors and Signal Transduction · doi:10.1080/10799893.2018.1456552 · Cited by 24
Beyond glucose and Warburg: finding the sweet spot in cancer metabolism models
Hammond, N. G., Cameron, R. B., & Faubert, B. (2024) · npj Metabolic Health and Disease · doi:10.1038/s44324-024-00017-2 · Cited by 23
Metabolic adaptations in cancer progression
Peng‐Winkler, Y., & Fendt, S. (2025) · Physiological Reviews · doi:10.1152/physrev.00037.2024 · Cited by 25
Glucose metabolism and its direct action in cancer and immune regulation: opportunities and challenges for metabolic targeting
Pan, B., Hsu, C.-C., Wu, H., Chen, Y.-R., Zhou, X., Wang, S., Li, C., & Lin, H.-K. (2025) · Journal of Biomedical Science · doi:10.1186/s12929-025-01167-1 · Cited by 27
Translating In Vitro T Cell Metabolic Findings to In Vivo Tumor Models of Nutrient Competition
Ecker, C., & Riley, J. L. (2018) · Cell Metabolism · doi:10.1016/j.cmet.2018.07.009 · Cited by 22
The fuel and engine: The roles of reprogrammed metabolism in metastasis of primary liver cancer
Zhu, W., Lü, M., Wang, X., Xu, Z., Gao, C., & Qin, L. (2020) · Genes & Diseases · doi:10.1016/j.gendis.2020.01.016 · Cited by 25
Regulation of immune cell metabolism in health and disease: Special focus on T and B cell subsets
Chakraborty, S., Khamaru, P., & Bhattacharyya, A. (2022) · Cell Biology International · doi:10.1002/cbin.11867 · Cited by 24
Advances and Hurdles in CAR T Cell Immune Therapy for Solid Tumors
Boccalatte, F. E., Mina, R., Aroldi, A., Leone, S., Suryadevara, C. M., Placantonakis, D. G., & Bruno, B. (2022) · Cancers · doi:10.3390/cancers14205108 · Cited by 24
Metabolic reprogramming by miRNAs in the tumor microenvironment: Focused on immunometabolism
Alshahrani, S. H., Ibrahim, Y. S., Jalil, A. T., Altoum, A. A., Achmad, H., Zabibah, R. S., Gabr, G. A., Ramírez‐Coronel, A. A., Alameri, A. A., Qasim, Q. A., et al. (2022) · Frontiers in Oncology · doi:10.3389/fonc.2022.1042196 · Cited by 24
Calcium signalling in hepatic metabolism: Health and diseases
Humbert, A., Lefebvre, R., Nawrot, M., Caussy, C., & Rieusset, J. (2023) · Cell Calcium · doi:10.1016/j.ceca.2023.102780 · Cited by 28
Interaction and Collaboration of SP1, HIF-1, and MYC in Regulating the Expression of Cancer-Related Genes to Further Enhance Anticancer Drug Development
Kimura, K., Jackson, T. L. B., & Huang, R. C. C. (2023) · Current Issues in Molecular Biology · doi:10.3390/cimb45110580 · Cited by 27
Immune Escape Strategies in Head and Neck Cancer: Evade, Resist, Inhibit, Recruit
Kostecki, K. L., Iida, M., Crossman, B. E., Salgia, R., Harari, P. M., Bruce, J. Y., & Wheeler, D. L. (2024) · Cancers · doi:10.3390/cancers16020312 · Cited by 26
Engineering T Cells to Treat Cancer: The Convergence of Immuno-Oncology and Synthetic Biology
Choe, J. H., Williams, J. Z., & Lim, W. A. (2020) · Annual Review of Cancer Biology · doi:10.1146/annurev-cancerbio-030419-033657 · Cited by 23
Cholesterol metabolites and tumor microenvironment: the road towards clinical translation
Raccosta, L., Fontana, R., Corna, G., Maggioni, D., Moresco, M. A., & Russo, V. E. A. (2015) · Cancer Immunology Immunotherapy · doi:10.1007/s00262-015-1779-0 · Cited by 23
Targeting metabolism to improve CAR-T cells therapeutic efficacy
Liu, S., Zhao, Y., Gao, Y., Li, F., & Zhang, Y. (2024) · Chinese Medical Journal · doi:10.1097/cm9.0000000000003046 · Cited by 24
Metabolic mechanisms of immunotherapy resistance
Cabezón‐Gutiérrez, L., Palka-Kotlowska, M., Custodio‐Cabello, S., Chacón-Ovejero, B., & Pacheco-Barcía, V. (2025) · Exploration of Targeted Anti-tumor Therapy · doi:10.37349/etat.2025.1002297 · Cited by 26
ICI-induced cardiovascular toxicity: mechanisms and immune reprogramming therapeutic strategies
Zheng, J., Yi, Y., Tian, T., Luo, S., Liang, X., & Bai, Y. (2025) · Frontiers in Immunology · doi:10.3389/fimmu.2025.1550400 · Cited by 24
Deciphering the deterministic role of TCR signaling in T cell fate determination
Qin, Z., & Xu, T. (2025) · Frontiers in Immunology · doi:10.3389/fimmu.2025.1562248 · Cited by 30
Rewiring cancer metabolism: oncogenic signaling pathways and targeted therapeutics
Lyu, S., Gildor, N., Zhang, Q. H., & Liao, C. (2025) · Science China Life Sciences · doi:10.1007/s11427-025-2979-3 · Cited by 27
Cereblon harnesses Myc-dependent bioenergetics and activity of CD8+ T lymphocytes
Hesterberg, R. S., Beatty, M. S., Han, Y., Fernandez, M. R., Akuffo, A. A., Goodheart, W. E., Yang, C., Chang, S., Colin, C., Alontaga, A. Y., et al. (2020) · Blood · doi:10.1182/blood.2019003257 · Cited by 22
Ion Channels, Transporters, and Sensors Interact with the Acidic Tumor Microenvironment to Modify Cancer Progression
Boedtkjer, E. (2021) · Reviews of physiology, biochemistry and pharmacology · doi:10.1007/112_2021_63 · Cited by 22
Nutrient Condition in the Microenvironment Determines Essential Metabolisms of CD8+ T Cells for Enhanced IFNγ Production by Metformin
Chao, R., Nishida, M., Yamashita, N., Tokumasu, M., Zhao, W., Kudo, I., & Udono, H. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.864225 · Cited by 23
Phenotypic, functional, and metabolic heterogeneity of immune cells infiltrating non–small cell lung cancer
Aramini, B., Masciale, V., Samarelli, A. V., Dubini, A., Gaudio, M., Stella, F., Morandi, U., Dominici, M., Biasi, S. D., Gibellini, L., et al. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.959114 · Cited by 23
Increased tumor glycolysis is associated with decreased immune infiltration across human solid tumors
Cohen, I., Pareja, F. G., Socci, N. D., Shen, R., Doane, A. S., Schwartz, J., Khanin, R., Morris, E. A., Sutton, E. J., & Blasberg, R. G. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.880959 · Cited by 24
Mitochondrial Metabolism in Pancreatic Ductal Adenocarcinoma: From Mechanism-Based Perspectives to Therapy
Padinharayil, H., Rai, V., & George, A. (2023) · Cancers · doi:10.3390/cancers15041070 · Cited by 26
Functions of Key Enzymes of Glycolytic Metabolism in Tumor Microenvironment
Xu, W., Weng, J., Xu, M., Zhou, Q., Liu, S., Hu, Z., Ren, N., Zhou, C., & Shen, Y.-H. (2023) · Cellular Reprogramming · doi:10.1089/cell.2023.0010 · Cited by 23
The nexus of dynamic T cell states and immune checkpoint blockade therapy in the periphery and tumor microenvironment
Luo, H., Wang, W., Mai, J., Yin, R., Cai, X., & Li, Q. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1267918 · Cited by 22
Focusing on CD8+ T-cell phenotypes: improving solid tumor therapy
Yao, Z., Zeng, Y., Liu, C., Jin, H., Wang, H., Zhang, Y., Ding, C., Chen, G., & Wu, D. (2024) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-024-03195-5 · Cited by 27
Engineering CAR‐T Therapeutics for Enhanced Solid Tumor Targeting
Zhu, D., Kim, W., Lee, H., Bao, X., & Kim, P. (2025) · Advanced Materials · doi:10.1002/adma.202414882 · Cited by 24
Cholesterol homeostasis and lipid raft dynamics at the basis of tumor-induced immune dysfunction in chronic lymphocytic leukemia
Jacobs, C. F., Peters, F. S., Camerini, E., Cretenet, G., Rietveld, J. M., Schomakers, B. V., van Weeghel, M., Hahn, N., Verberk, S. G. S., den Bossche, J. V., et al. (2025) · Cellular and Molecular Immunology · doi:10.1038/s41423-025-01262-1 · Cited by 23
Cancer Stem Cells Connecting to Immunotherapy: Key Insights, Challenges, and Potential Treatment Opportunities
Mathan, S. V., & Singh, R. P. (2025) · Cancers · doi:10.3390/cancers17132100 · Cited by 24
Mitochondria and lysosomes in T cell immunometabolism
Norton, E. G., Chapman, N. M., & Chi, H. (2025) · Trends in Immunology · doi:10.1016/j.it.2025.07.014 · Cited by 24

Authors: Ho, P.-C., Bihuniak, J. D., Macintyre, A. N., Staron, M., Liu, X., Amezquita, R., Tsui, Y.-C., Cui, G., Micevic, G., Perales, J. C., Kleinstein, S. H., Abel, E. D., Insogna, K. L., Feske, S., Locasale, J. W., Bosenberg, M. W., Rathmell, J. C., & Kaech, S. M.
Affiliations: Yale University (US)
Duke University (US)
Cornell University (US)
Howard Hughes Medical Institute (US)
Institut d'Investigació Biomédica de Bellvitge (ES)
University of Iowa (US)
NYU Langone Health (US)
Corresponding author: Ho, Ping-Chih
Kaech, Susan M.
ORCID: Ho, Ping-Chih
Bihuniak, Jessica Dauz
Macintyre, Andrew N.
Liu, Xiaojing
Amezquita, Robert
Cui, Guoliang
Micevic, Goran
Perales, Jose C.
Kleinstein, Steven H.
Abel, E. Dale
Insogna, Karl L.
Feske, Stefan
Locasale, Jason W.
Bosenberg, Marcus W.
Rathmell, Jeffrey C.
Kaech, Susan M.
Venue: Cell
Publisher: Elsevier BV
Published: 2015-09
Volume: 162
Issue: 6
Pages: 1217-1228
ISSN: 0092-8674 (ISSN-L)
DOI: 10.1016/j.cell.2015.08.012
PMC: PMC4567953
OpenAlex: W2160551785
Cited by: 1,462
References: 47
Citations by year: 2026: 125 · 2025: 148 · 2024: 127 · 2023: 147 · 2022: 155 · 2021: 168 · 2020: 156 · 2019: 116 · 2018: 116 · 2017: 110 · 2016: 84 · 2015: 10
FWCI: 35.25
Type: journal article
Language: en
Open access: bronze
doi.org
Licence: www.elsevier.com/tdm/userlicense/1.0/ (tdm)
www.elsevier.com/open-access/userlicense/1.0/ (vor, 375 d)
Locations: Cell (publishedVersion)
PubMed (publishedVersion)
PubMed Central (acceptedVersion)
Funders: Howard Hughes Medical Institute
National Heart, Lung, and Blood Institute (R01HL108006)
National Cancer Institute (R00CA168997, R01CA123350, F30CA196089, P50CA121974, P30CA016359)
National Institute of General Medical Sciences (T32GM007205)
National Institute of Allergy and Infectious Diseases (R01AI110613, R37AI066232, R01AI063345, R01AI097302, R01AI074699, R01AI066232)
National Institute of Arthritis and Musculoskeletal and Skin Diseases (P30AR053495)
Topics: Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer, Hypoxia, and Metabolism
Health Sciences › Medicine › Oncology › Cancer Immunotherapy and Biomarkers
Life Sciences › Immunology and Microbiology › Immunology › T-cell and B-cell Immunology
Keywords: phosphoenolpyruvate, T cell metabolism, tumor-infiltrating T cells, aerobic glycolysis, tumor microenvironment, PCK1, SERCA, calcium signaling, NFAT, T cell effector function, metabolic reprogramming, antitumor immunity, melanoma, immunotherapy
MeSH terms: Animals, Calcium, Endoplasmic Reticulum, Glycolysis, Hexokinase, Immunotherapy, Melanoma, Phosphoenolpyruvate, Receptors, Antigen, T-Cell, Monitoring, Immunologic, Signal Transduction, CD4-Positive T-Lymphocytes, Transforming Growth Factor beta, Lymphocytes, Tumor-Infiltrating, NFATC Transcription Factors, Mice, Sarcoplasmic Reticulum Calcium-Transporting ATPases, Tumor Microenvironment

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Phosphoenolpyruvate Is a Metabolic Checkpoint of Anti-tumor T Cell Responses

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Self-check

Citations

Cites

Cited by

Related

Metadata

Record

About these checks